BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16297010)

  • 1. The future: critical knowledge about anti-itch therapy.
    Guarneri C; Terranova M; Terranova G; Guarneri F
    Dermatol Ther; 2005; 18(4):363-5. PubMed ID: 16297010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic advances in the systemic treatment of itch.
    Summey BT; Yosipovitch G
    Dermatol Ther; 2005; 18(4):328-32. PubMed ID: 16297005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic pruritus: targets, mechanisms and future therapies.
    Pogatzki-Zahn E; Marziniak M; Schneider G; Luger TA; Ständer S
    Drug News Perspect; 2008 Dec; 21(10):541-51. PubMed ID: 19221635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic drugs with antipruritic potency.
    Weisshaar E; Gollnick H
    Skin Therapy Lett; 2000; 5(5):1-2,5. PubMed ID: 10854341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical anti-itch therapy.
    Hercogová J
    Dermatol Ther; 2005; 18(4):341-3. PubMed ID: 16297007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurophysiological and neurochemical basis of modern pruritus treatment.
    Ständer S; Weisshaar E; Luger TA
    Exp Dermatol; 2008 Mar; 17(3):161-9. PubMed ID: 18070080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizations of sphingosylphosphorylcholine-induced scratching responses in ICR mice using naltrexon, capsaicin, ketotifen and Y-27632.
    Kim HJ; Kim H; Han ES; Park SM; Koh JY; Kim KM; Noh MS; Kim JJ; Lee CH
    Eur J Pharmacol; 2008 Mar; 583(1):92-6. PubMed ID: 18289521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathic and psychogenic itch.
    Yosipovitch G; Samuel LS
    Dermatol Ther; 2008; 21(1):32-41. PubMed ID: 18318883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different roles of capsaicin-sensitive and H1 histamine receptor-expressing sensory neurones in itch of mosquito allergy in mice.
    Nakano T; Andoh T; Sasaki A; Nojima H; Kuraishi Y
    Acta Derm Venereol; 2008; 88(5):449-54. PubMed ID: 18779880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical capsaicin 8% for the treatment of neuropathic itch conditions.
    Andersen HH; Arendt-Nielsen L; Elberling J
    Clin Exp Dermatol; 2017 Jul; 42(5):596-598. PubMed ID: 28556308
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel agents for intractable itch.
    Lynde CB; Kraft JN; Lynde CW
    Skin Therapy Lett; 2008 Feb; 13(1):6-9. PubMed ID: 18357364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease mechanisms in neuropathic itch.
    Binder A; Koroschetz J; Baron R
    Nat Clin Pract Neurol; 2008 Jun; 4(6):329-37. PubMed ID: 18461071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scratching the surface--Managing the itch associated with burns: a review of current knowledge.
    Brooks JP; Malic CC; Judkins KC
    Burns; 2008 Sep; 34(6):751-60. PubMed ID: 18375072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contact irritant dermatitis and anti-pruritic agents: the need to address the itch.
    Burkhart CG; Burkhart HR
    J Drugs Dermatol; 2003 Apr; 2(2):143-6. PubMed ID: 12852365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and emerging systemic treatments targeting the neural system for chronic pruritus.
    Golpanian RS; Yosipovitch G
    Expert Opin Pharmacother; 2020 Sep; 21(13):1629-1636. PubMed ID: 32515664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pruritus measurement and treatment.
    Langner MD; Maibach HI
    Clin Exp Dermatol; 2009 Apr; 34(3):285-8. PubMed ID: 19309370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone for the management of post-burn pruritus: A preliminary report.
    LaSalle L; Rachelska G; Nedelec B
    Burns; 2008 Sep; 34(6):797-802. PubMed ID: 18325676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psyche, opioids, and itch: therapeutic consequences.
    Krishnan A; Koo J
    Dermatol Ther; 2005; 18(4):314-22. PubMed ID: 16297003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How best to fight that nasty itch - from new insights into the neuroimmunological, neuroendocrine, and neurophysiological bases of pruritus to novel therapeutic approaches.
    Biró T; Ko MC; Bromm B; Wei ET; Bigliardi P; Siebenhaar F; Hashizume H; Misery L; Bergasa NV; Kamei C; Schouenborg J; Roostermann D; Szabó T; Maurer M; Bigliardi-Qi M; Meingassner JG; Hossen MA; Schmelz M; Steinhoff M
    Exp Dermatol; 2005 Mar; 14(3):225-40. PubMed ID: 15740597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.